Effect of short-term antenatal dexamethasone administration on type I collagen synthesis and degradation in preterm infants at birth

Acta Paediatrica, International Journal of Paediatrics

Volumn 90, Issue 8, 2001, Pages 921-925

  Saarela, T ^a   Risteli, J ^b   Kauppila, A ^b   Koivisto, Maila ^a  

^a Department of Paediatrics ^*  (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Antenatal glucocorticoids; Collagen degradation; Collagen synthesis; Preterm infant

Indexed keywords

COLLAGEN TYPE 1; DEXAMETHASONE; PROCOLLAGEN;

ARTICLE; BLOOD LEVEL; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FETUS LUNG MATURITY; HIGH RISK PREGNANCY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT COURSE THERAPY; UMBILICAL CORD BLOOD;

EID: 0034890810     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2001.tb02458.x     Document Type: Article

References (25)

1. Antenatal corticoid therapy: A meta-analysis of the randomized trials
2. Effect of corticosteroids for fetal maturation on perinatal outcomes
3. Multiple courses of antenatal corticosteroids and outcome of premature neonates
4. The placental transfer of betamethasone
5. The effect of maternal betamethasone administration on the fetus
6. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities
7. Repeated antenatal corticosteroids: Size at birth and subsequent development
8. Corticosteroids and growth
9. Growth retardation after dexamethasone administration: Assessment by knemometry
10. Antenatal corticosteroid therapy and risk of osteoporosis
11. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: Loss of antigenicity by treatment with cathepsin K.
12. New Finnish foetal growth charts
13. Immunoassay for intact amino-terminal propeptide of human type I collagen
14. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
15. Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments
16. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids
17. Products of bone collagen metabolism
18. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry
19. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: Relation to calcium kinetics
20. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants
21. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study
22. Is alkaline phosphatase an adequate marker of bone metabolism during acute corticosteroid treatment?
23. Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment
24. The insulin-like growth factor axis and collagen turnover during prednisolone treatment
25. Age-dependent effect of oral corticosteroids on markers of bone resorption in patients with acute asthma